Kinfo
Niagen Bioscience Inc. logo

Niagen Bioscience Inc.

NAGENASDAQConsumer Defensive·US · USD
$2.69
+0.01 (+0.37%)
Prices as of October 6, 2026 · market closed

Price

Key statistics

Valuation
Market cap214.24M USD
Enterprise value156.97M USD
Trailing P/E14.68
Forward P/E27.90
PEG ratio-0.18
Price / sales1.72
Price / book2.67
Profitability
Gross margin64.84%
Operating margin2.35%
Profit margin12.39%
Return on assets5.44%
Return on equity21.80%
Income (TTM)
Revenue129.08M USD
Gross profit82.92M USD
EBITDA13.76M USD
Net income15.99M USD
Diluted EPS$0.19
Rev. growth (YoY)-4.30%
Balance sheet
Total cash66.59M USD
Total debt2.33M USD
Debt / equity2.82
Current ratio6.50
Book value / share$1.04
Cash flow (TTM)
Operating cash flow5.95M USD
Levered free cash flow1.64M USD
Shares & price
Shares outstanding78.91M
Float59.07M
Held by institutions41.53%
Beta2.09
50-day MA$3.11
200-day MA$4.31
52-week high$7.95
52-week low$2.61
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-08-04-0.010.01+200.00%2026-05-060.060.02−66.67%2026-03-040.020.03+50.00%2026-02-121.031.07+3.88%2026-01-131.361.52+11.76%
About Niagen Bioscience Inc.

Niagen Bioscience Inc. is a bioscience company focused on healthy aging and NAD+ science. It develops and commercializes proprietary ingredient technologies and finished dietary supplement products centered on nicotinamide riboside and related NAD+ precursors. The company serves consumer, ingredient, analytical reference standards and services, and pharmaceutical markets through products used in dietary supplements, food and beverage formulations, skin care applications, and research settings. Niagen Bioscience also supplies ingredient raw materials to manufacturers and supports scientific and quality-control work through its analytical and reference standards offerings. Its current portfolio is built around the Niagen platform, which anchors the company’s consumer brands and broader ingredient business, making Niagen Bioscience a specialized participant in the health and wellness, nutraceutical, and bioscience sectors.

Sector
Consumer Defensive
Industry
Packaged Foods
CEO
Mr. Robert N. Fried
Employees
117
Headquarters
Los Angeles, CA, United States

Frequently asked questions about Niagen Bioscience Inc.